Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
13 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Targretin“
Suchtreffer
Begriffe & Kennungen
Targretin · 4.8 · Bexarotene has a different adverse reaction profile to other oral, non-retinoid X receptor (RXR)-selective ret
Eintrag öffnenTargretin · 4.8 · Hypothyroidism generally occurs 4-8 weeks after commencement of therapy. It may be asymptomatic and responds t
Eintrag öffnenTargretin · 4.8 · In 109 patients with CTCL treated at the recommended initial dose of 300 mg/m2/day, the most commonly reported
Eintrag öffnenTargretin · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenTargretin · 4.8 · Single observations of the following were also reported: bone marrow depression, decreased prothrombin, decrea
Eintrag öffnenTargretin · 4.8 · Summary of the safety profile
Eintrag öffnenTargretin · 4.8 · Table 2 Adverse reactions reported in patients in clinical trials System Organ Class Very Common Common Uncomm
Eintrag öffnenTargretin · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenTargretin · 4.8 · The following Targretin-related adverse reactions were reported during clinical studies in patients with CTCL
Eintrag öffnenTargretin · 4.8 · The majority of adverse reactions were noted at a higher incidence at doses greater than 300 mg/m2/day. Genera
Eintrag öffnenTargretin · 4.8 · The safety of bexarotene has been examined in clinical studies of 193 patients with CTCL who received bexarote
Eintrag öffnenTargretin · 4.8 · Vomiting Diarrhoea1,3 Nausea3 Anorexia1 Pancreatitis1,3 Gastrointestinal Liver Function Tests Abnormal Hepatic
Eintrag öffnenTargretin · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnen